Extralehdet Extralehdet
FDA aims to speed biosimilar approvals to increase competition, but experts warn drug prices may not drop quickly.
Latest posts by Toimitus (see all)
Why are biologic drugs expensive? Will Trump’s plans make them cheaper?
